Blue Sail MedicalLtd Management

Management criteria checks 3/4

Blue Sail MedicalLtd's CEO is Shuqiao Zhong, appointed in Jan 2022, has a tenure of 2.83 years. directly owns 0.044% of the company’s shares, worth CN¥2.36M. The average tenure of the management team and the board of directors is 2.6 years and 6.2 years respectively.

Key information

Shuqiao Zhong

Chief executive officer

CN¥2.2m

Total compensation

CEO salary percentage	n/a
CEO tenure	2.8yrs
CEO ownership	0.04%
Management average tenure	2.6yrs
Board average tenure	6.2yrs

Recent management updates

Recent updates

CEO

Shuqiao Zhong (39 yo)

2.8yrs

Tenure

CN¥2,160,000

Compensation

Mr. Shuqiao Zhong served as Secretary of Blue Sail Medical Co.,Ltd. since October 12, 2018 until July 29, 2022 and has also been its Non-Independent Director since September 13, 2018. He served as General...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Shuqiao Zhong	President	2.8yrs	CN¥2.16m	0.044% CN¥ 2.4m
Yuntao Cui	VP, Accounting Supervisor & CFO	2.6yrs	CN¥1.81m	no data
Jie Huang	VP, Chief Legal Officer & Board Secretary	2.6yrs	CN¥1.34m	no data

2.6yrs

Average Tenure

46yo

Average Age

Experienced Management: 002382's management team is considered experienced (2.6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Shuqiao Zhong	President	6.2yrs	CN¥2.16m	0.044% CN¥ 2.4m
Zhenping Li	Non-Independent Director	14.6yrs	CN¥1.74m	0.55% CN¥ 29.9m
Wenjing Liu	Chairman	11.6yrs	CN¥2.21m	0.37% CN¥ 19.8m
Zhou Zhiwei	Non-Employee Supervisor	10.5yrs	no data	no data
Shengjun Liu	Independent Director	6.2yrs	CN¥100.00k	no data
Shukui Dong	Independent Director	6.2yrs	CN¥100.00k	no data
Qiuyue Zong	Employee Representative Supervisor	3.9yrs	no data	0.00095% CN¥ 51.2k
Suhua Yu	Director	2.5yrs	CN¥1.99m	0.019% CN¥ 1.0m
Guitao Qiao	Independent Director	1.5yrs	no data	no data
Lingwei Lu	Chairman of the Supervisor Board	1.5yrs	no data	no data

6.2yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 002382's board of directors are considered experienced (6.2 years average tenure).

Blue Sail MedicalLtd Management

Management criteria checks 3/4

Key information

Recent management updates

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

Blue Sail Medical Co.,Ltd. Approves Board Appointments

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 22, 2023

High number of new directors

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 05, 2022

Recent updates

Third quarter 2024 earnings released: CN¥0.06 loss per share (vs CN¥0.12 loss in 3Q 2023)

Blue Sail Medical Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Blue Sail Medical Co.,Ltd.(XSEC:002382) dropped from FTSE All-World Index (USD)

New major risk - Financial data availability

Second quarter 2024 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 2Q 2023)

Blue Sail Medical Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

First quarter 2024 earnings released: CN¥0.10 loss per share (vs CN¥0.08 loss in 1Q 2023)

Blue Sail Medical Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Blue Sail Medical Co.,Ltd. (SZSE:002382) commences an Equity Buyback Plan for CNY 50 million worth of its shares, under the authorization approved on March 11, 2024.

Blue Sail Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: CN¥0.12 loss per share (vs CN¥0.033 profit in 3Q 2022)

Blue Sail Medical Co.,Ltd. to Report Q3, 2023 Results on Oct 31, 2023

Second quarter 2023 earnings released: CN¥0.15 loss per share (vs CN¥0.13 loss in 2Q 2022)

Blue Sail Medical Co.,Ltd. Approves Board Appointments

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 22, 2023

First quarter 2023 earnings released: CN¥0.08 loss per share (vs CN¥0.05 loss in 1Q 2022)

Third quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.024 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.13 loss per share (vs CN¥1.69 profit in 2Q 2021)

High number of new directors

First quarter 2022 earnings released: CN¥0.05 loss per share (vs CN¥1.69 profit in 1Q 2021)

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 05, 2022

Blue Sail Medical Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

Full year 2021 earnings released: EPS: CN¥1.13 (vs CN¥1.82 in FY 2020)

Third quarter 2021 earnings released: CN¥0.024 loss per share (vs CN¥1.31 profit in 3Q 2020)

Investor sentiment deteriorated over the past week

Blue Sail Medical Co.,Ltd. Proposes Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥1.81 (vs CN¥0.51 in FY 2019)

New 90-day low: CN¥20.43

Blue Sail Medical Co.,Ltd. to Report Fiscal Year 2020 Results on Apr 10, 2021

New 90-day high: CN¥26.29

New 90-day low: CN¥20.00

New 90-day low: CN¥22.36

Third quarter earnings released

Blue Sail Medical Co.,Ltd. to Report First Half, 2020 Results on Aug 31, 2020

Blue Sail Medical Co.,Ltd. (SZSE:002382) acquired Wuhan Bikaier Rescue Supplies Co., Ltd. from Zhuhai Blue Sail Juqing Equity Investment Center (Limited Partnership), Sui Jianxun and Fan Furong for approximately CNY 290 million.

Blue Sail Medical Co.,Ltd. (SZSE:002382) completed the acquisition of remaining 6.6% stake in CB Cardio Holdings II Limited from CPBL Limited.

Zhongtai Asset Management cancelled the acquisition of 5.1% stake in Blue Sail Medical Co.,Ltd. (SZSE:002382) from Lanfan Group Co., Ltd

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age